Lexaria Bioscience Corp. Warrant (LEXXW) Key Ratios
$0.00
As on 13-Jan-2026 15:34EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 52.05 | 40.34 | 17.53 |
| EBIT | 40.84 | 41.04 | -105.06 | -27.14 | -197.28 |
| Net Profit | 40.90 | 41.03 | -105.37 | -28.68 | -200.50 |
| EPS | -- | -- | -- | -- | -- |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Aug-25 | Aug-24 |
| EBIT-Margin
| -- | -- | -2,069.06 | -1,687.36 | -1,251.12 |
| Net Margin
| -- | -- | -2,067.65 | -- | -- |
| Return on equity
| -- | -- | -206.10 | -215.88 | -104.60 |
| Return on Capital
| -- | -- | -- | -211.16 | -101.83 |
| Return on Assets
| -- | -- | -122.66 | -182.50 | -96.98 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.04 | 0.02 |
The underlying data is unavailable.